Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 08, 2026
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 07, 2026
Large language models provide unsafe answers to patient-posed medical questions.
Journal: NPJ digital medicine
Published: August 04, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026